Atrial fibrosis is considered to be a key driver to the initiation and perpetuation of atrial fibrillation (AF). Histological studies evaluating human atrial fibrosis are largely restricted to tissue samples that can be collected during cardiac surgery such as atrial appendage tissue.
1,2 Consequently, left atrial (LA) appendage (LAA) tissue is often used as a surrogate marker for the entire LA to assess processes of structural remodelling related to AF. Animal studies suggest that LAA tissue may act as a decent representation of the LA as the cellular composition of murine LAA and LA-body tissue was found to be rather similar.
3 To the best of our knowledge however, it remains unclear whether the fibrosis content assessed in human appendage samples accurately represents the fibrosis content of the entire LA.